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Syk protein tyrosine kinase is essential for immune Results and discussion
We examined the possibility of direct interactions be-system development and function [1] and for the
maintenance of vascular integrity [2, 3]. In tween Syk and integrins because Syk activation is an early
response to integrin clustering [6] and Syk is found inleukocytes, Syk is activated by binding to
diphosphorylated immune receptor tyrosine-based a protein complex that contains integrins [7, 8]. When
platelets adhered to the IIb3 ligand fibrinogen, Sykactivation motifs (pITAMs) [1]. Syk can also be
activated by integrin adhesion receptors [4, 5], but coprecipitated with integrin IIb3 (Figure 1a). Because
integrin-dependent Syk activation [4] depends on integrinthe mechanism of its activation is unknown. Here
we report a novel mechanism for Syk’s recruitment cytoplasmic domains [5], we tested for interactions be-
and activation, which requires that Syk bind to the tween Syk and recombinant model protein mimics of
integrin 3 cytoplasmic tail. We found that both Syk dimerized integrin cytoplasmic tails. The model proteins
and the related kinase ZAP-70 bound the 3 are designed with an N-terminal heptad repeat sequence
cytoplasmic tail through their tandem SH2 domains. joined to the integrin cytoplasmic domains. The repeats
However, unlike Syk binding to pITAMs, this form a coiled-coil homodimer that dimerizes the integrin
interaction was independent of tyrosine tails [9]. Syk and Zap-70 from cell lysates bound to a 3
phosphorylation and of the phosphotyrosine tail model protein (Figure 1b). This association must have
binding function of Syk’s tandem SH2 domains. been specific because there was no detectable binding to
Deletion of the four C-terminal residues of the 3 the IIb tail (Figure 1b) or to a structure-altering [10] 3
cytoplasmic tail [3(759X)] decreased Syk binding tail point mutant 3(Y747A) that perturbs many integrin
and disrupted its physical association with integrin functions [11] (data not shown). Furthermore, Syk and
IIb3. Furthermore, cells expressing IIb3(759X) its paralog, Zap-70, were enriched to a greater extent
failed to exhibit Syk activation or lamellipodia than Talin (see Figure S1 in the supplementary material
formation upon cell adhesion to the IIb3 ligand, available with this article online), a protein known to
fibrinogen. In contrast, FAK phosphorylation and interact directly with integrin  cytoplasmic tails [9, 12].
focal adhesion formation were unimpaired by this To localize 3 integrin binding sites within Syk, we exam-
mutation. Thus, the direct binding of Syk kinase to ined the binding of recombinant wild-type and mutant
the integrin 3 cytoplasmic tail is a novel and Syk expressed in CHO cells. Wild-type Syk bound to the
functionally significant mechanism for the 3 tail (Figure 1c, left panel). Neither kinase activity nor
regulation of this important non-receptor tyrosine the kinase domain of Syk was required for binding since
kinase. both a kinase-inactive Syk(K402R) and a Syk truncation
mutant (residues 1–330) lacking the kinase domain bound
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SH2 domains of Syk recognize phosphorylated tyrosine
residues in consensus pITAMmotifs [YxxI/L(x)6–8YxxI/L]
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Figure 1 Figure 2
Adhesion-dependent association between Syk and integrin IIb3.
(a) Integrin IIb3 (left panel) or Syk (right panel) was immuno-
precipitated from lysates of fibrinogen (Fib)-adherent or suspended
(Sus) platelets, followed by probing with anti-Syk or anti-3,
respectively. “NRS” stands for normal rabbit serum. “Lys” stands for
platelet lysate. (b) Affinity chromatography of B cell lysates or Jurkat
T cell lysates. Integrin IIb and 3 cytoplasmic-domain model proteins
were used. (c) CHO cells expressing various wild-type and mutant
Syk constructs were lysed, and affinity chromatography was performed Direct interaction between Syk and the 3 tail involves Syk’s tandem
with integrin IIb and 3 cytoplasmic domains. Coomassie blue SH2 domain but is independent of phospho-ITAM binding. (a) Syk and
staining of the integrin cytoplasmic-domain model proteins was used Zap-70 direct binding to the integrin 3 cytoplasmic tail. The doublet
for monitoring the loading of the affinity matrix (Loading). The last (approximately 70 and 62 kDa) of Syk(6–370) seen when one blots
lane of each immunoblot represents 1/20th of the starting cell lysate with anti-GST represents intact Syk(6–370), a C-terminal cleavage of
(Lys). Depicted is one representative experiment of three performed. the purified GST-fusion protein. Coomassie blue staining of the
integrin cytoplasmic domain model proteins was used for monitoring
the loading of each construct (Loading). (b) Direct binding of 3
tails to purified Syk(6–370) in the presence of excess phospho-ITAM
in immune response receptor subunits [1]. However, in- (pITAM) peptides. Peptides proved to be functional because they
activated Syk kinase in vitro ([14] and data not shown). All experimentstegrin activation of Syk appears to be ITAM independent
were repeated 3–6 times, and representative results are shown. (c)[5]. Indeed, a C-terminal SH2 domain mutant of Syk that
Elisa analysis of soluble 3 tail binding to immobilized GST-is deficient in binding to pITAMs, but which can be
Syk(6–370) in the presence of FcRI pITAM. The inset image
activated by integrin IIb3 [Syk(R195A)] [5], bound to shows specific inhibition of the binding of the integrin 3 tail to
the 3 cytoplasmic tail (see Figure S2 in the supplemen- immobilized GST-Syk. NT represents no treatment. Experiments
were repeated 3–6 times, and representative results are shown.tary material). Additional mapping studies (our unpub-
lished results) indicated that Syk(6–270) bound to the
integrin 3 tail; however, Syk(163–270), which contains
only the C-terminal SH2 domain, failed to bind. We intro- phosphorylated FcRI ITAM peptide [DGVY(PO3)
TGLSTRNQETY(PO3)ETLKTCR] failed to competeduced an R42A mutation (predicted to disrupt the phos-
photyrosine binding pocket in the N-terminal SH2 do- with the 3 integrin cytoplasmic tail for binding to Syk(6–
370) (Figure 2b). pITAM peptide derived from the TCRmain) into the Syk(6–270) construct to test its effects on
binding to the 3 tail. This mutation failed to prevent its chain (Figure 2b) also failed to compete. Soluble pITAM
peptide was used at a concentration of 40 M, well abovebinding to the 3 tail in direct binding assays (see Figure
S2 in the supplementary material), suggesting that the the reported 2.6 nM Kd for the interaction between
Syk(6–370) and the FcRI pITAM peptide [13]. In aSyk-3 interaction involved a novel, pITAM-indepen-
dent mechanism. To test this hypothesis, we examined quantitative enzyme-linked immunosorbent assay, immo-
bilized Syk(6–370) bound to the soluble 3 tail in thethe effect of an 8000-foldmolar excess of pITAMpeptides
on the binding of Syk(6–370) to the 3 tail. A dually presence or absence of 10 M FcRI pITAM peptides
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Figure 3
Removal of the four C-terminal residues of the 3 cytoplasmic tail CHO cells stably expressing wild-type integrin IIb3 or integrin
abrogates Syk binding both in vitro and in vivo. (a) Schematic IIb3(759X) that were kept in suspension (Sus) or plated on
representation of integrin 3 cytoplasmic tail deletion mutants. Shaded fibrinogen (Fib). Syk or integrin was immunoprecipitated and probed
boxes indicate deleted residues. (b) Direct binding of GST fusions for (c) integrin 3 or (d) Syk, respectively. Similar amounts of 3
of Syk(6–370) and Zap-70(1–337) to integrin 3 cytoplasmic tail integrin and Syk were expressed in both cell lines (see lower panels
deletion mutants. Bound protein was measured by Western blotting of parts [d] and [c], respectively). The figure depicts one
with anti-GST mAb. Bottom panel (Loading) depicts Coomassie representative experiment of three so performed.
staining of cytoplasmic tails. (c,d) Lysates were generated from
(Figure 2c), confirming the lack of competition. The abrogates binding in vitro. We assessed the effect of the
deletion of these residues on the association between SykFcRI pITAM peptides were shown to be functional
because they activated Syk kinase (EC50 1–2 uM) in vitro and integrin IIb3. CHO cells expressing IIb3(759X)
were generated (see Figure S3 in the supplementary ma-[14] (data not shown). Thus, Syk recognition of 3 in-
volves a unique specificity, distinct from Syk’s interaction terial). These cells expressed similar quantities of IIb3
(Figure S3) and adhered normally to fibrinogen (data notwith pITAMs.
shown), but unlike wild-type IIb3, IIb3(759X) was
not coimmunoprecipitated with Syk (Figure 3c,d) fromTo identify regions of the 3 tail involved in Syk binding,
these adherent cells.we tested deletion mutants represented schematically in
Figure 3a. The N-terminal deletion 3(716–733) (which
removes residues 716–733 of the integrin 3 cytoplasmic When integrin IIb3(759X)-expressing CHO cells were
plated on fibrinogen, they spread and formed focal adhe-domain; Figure 3a) retained the ability to bind Syk and
Zap-70 (Figure 3b). However, deletion of seven more sions (see Figure S4 in the supplementary material) but
did not support adhesion-dependent Syk phosphorylationresidues [3(716–740)] prevented binding. Deletion of
the last four C-terminal residues (Tyr759-Arg-Gly-Thr762) (Figure 4a, lower panel). In contrast, these cells exhibited
adhesion-dependent phosphorylation of another tyrosine[3(759X)] abolished Syk interaction with 3, as did re-
moval of 11 C-terminal residues [residues Thr752–Thr762, kinase, pp125FAK (Figure 4a, upper panel). Thus, the phys-
ical association of integrin IIb3 with Syk requires the(3752X)] (Figure 3b). Thus, 3 residues Arg734-Thr762 are
sufficient for its direct interaction with Syk. Furthermore, Syk binding function of the 3 cytoplasmic tail and is
required for integrin-dependent activation of Syk. Theseremoval of the four C-terminal residues of integrin 3
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Figure 4
The Syk binding site in the 3 tail is required
for activation of Syk but not for activation of
pp125FAK. (a) Plating IIb3(759X)
expressing CHO cells on fibrinogen induced
the tyrosine phosphorylation of pp125FAK
(upper panels) but not Syk (lower panels). (b)
Phosphotyrosine analysis of pp125FAK, Syk,
and Vav1 in fibrinogen-adherent CHO cells
upon over-expression of Syk(1–330). CHO
cells stably expressing a retrovirally
transduced HA-tagged Syk were transfected
with vector control/Vav1 or Syk(1–330)/
Vav1. Syk, Vav1, or pp125FAK was
immunoprecipitated from lysates derived
from cells that were kept in suspension (Sus)
or plated on fibrinogen (Fib). (c) CHO cells
stably expressing integrin IIb3 or
IIb3(759X) were transfected with either
Vav1 or both Vav1 and Syk. Cells were plated
onto fibrinogen, fixed, and stained for Vav1
(FITC) and filamentous actin (rhodamine
phalloidin). Arrowheads indicate
lamellipodia. Quantification of lamellipodia
was performed in a blinded fashion, as
described [6]. The scale bar represents 10
m. All experiments were performed at least
three times, and representative results are
shown.
results also suggest that distinct 3 cytoplasmic-domain expressing IIb3 and a single genetic copy of Syk
blocked the integrin-dependent phosphorylation of Sykstructural features are responsible for the activation of
Syk and pp125FAK. (Figure 4b). Vav1, a Rac guanine nucleotide exchange
protein, is phosphorylated and activated upon binding
to phosphorylated Tyr348 of Syk [1]. Over-expression ofSyk activation upon integrin engagement is rapid and,
unlike pp125FAK activation, is insensitive to actin-depoly- Syk(1–330) also inhibited adhesion-dependent phosphor-
ylation of Vav1 (Figure 4b). These results confirm thatmerizing agents [6]. To further examine the dichotomy
between integrin-dependent regulation of Syk and sequences within the N-terminal half of Syk are involved
in its activation via binding to the 3 tail. Over-expressionpp125FAK, we used the tandem SH2 domains of Syk as a
dominant-negative inhibitor. In previous studies, low lev- of Syk(1–330) did not, however, inhibit adhesion-induced
phosphorylation of pp125FAK (Figure 4b). Thus, Syk acti-els of Syk(1–330) expression did not lead to detectable
inhibition of integrin-dependent Syk activation [5]. How- vation requires an integrin-dependent signaling pathway
that is distinct from that which activates pp125FAK, andever, over-expression of Syk(1–330) in CHO cells stably
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one can selectively block Syk activation and events down- activation defined here is likely to be of significance in
many biological contexts.stream of Syk without perturbing certain other signaling
functions of 3 integrins.
Materials and methods
Cells, cDNAs, and peptidesSyk and Vav1 cooperate to remodel the actin cytoskeleton
The CHO cell line expressing IIb3(759X) was generated by the trans-
by inducing Rac-dependent lamellipodia formation [6]. fection of CHO cells with IIb and 3(759X) cDNA. The CHO A5 cell
To assess the functional effects of the integrin-Syk inter- line stably expressing Syk-HA was created by retroviral transduction with
a C-terminal HA-tagged variant of Syk (pLHCX Syk-HA), followed byaction, we cotransfected CHO cells stably expressing wild-
selection in hygromycin.type IIb3 or IIb3(759X) with Vav1, or Syk and Vav1,
and assessed integrin-dependent lamellipodia formation. Fi- Mammalian Syk expression vectors have been described [5], along with
brinogen-adherent cells expressing integrin IIb3(759X) the bacterial expression vector GST-Syk(6–370) [21]. A cDNA encoding
residues 1–337 of human Zap-70 was cloned into pGEX-2T (Amershamgenerated at least one actin-rich lamellipodium in 28.3 
Pharmacia Biotech).1.0 percent of cells transfected with Vav1. Cotransfection
of Syk and Vav1 did not increase this response (26.3 
Phospo-ITAMs consisted of the dually phosphorylated FcRI chain ITAM,1.9 percent; Figure 4c). In sharp contrast, transfection DGVY(PO3)TGLSTRNQETY(PO3)ETLKTCR, and the dually phosphory-
of Syk and Vav1 into cells expressing wild-type IIb3 lated TCR chain ITAM, NQLY(PO3)NELNLGRREEY(PO3)DVLV [14].
resulted in a dramatic increase in the extent of lamelli-
podia formation (from 24.0 2.2 in Vav1-transfected cells Affinity chromatography/direct binding assays
All model protein mimics of integrin cytoplasmic domains were producedto 53.3 5.6 percent in Syk/Vav1-transfected cells, Figure
and characterized as previously reported [9, 10]. Ni		 beads coated4c). Thus, the interaction between Syk and the3 integrin
with integrin cytoplasmic tails (5 l packed) were added to 0.5 mgcytoplasmic domain initiates Syk-dependent cytoskeletal clarified cell lysate (affinity chromatography) or GST fusion protein (5
reorganization. nM) in a final volume of 0.5 ml binding buffer (see supplementary material
for details). After incubation, beads were washed, and bound protein
was analyzed via immunoblotting. For pITAM peptide competition assays,
GST-Syk(6–370) was preincubated with 40 M pITAMs, then directOur results suggest a novel paradigm for the regulation
binding assays were performed.of Syk kinases. Themechanism of Syk activation by integ-
rins differs from that of immune receptors. pITAMs
Elisa competition assaywithin immune receptors serve as the binding sites that
GST-Syk(6–370) was immobilized onto Immobilon II Elisa plates (Corn-recruit Syk through its tandem SH2 domains. In contrast, ing) in 0.1 M NaHCO3 (pH 8.0) for 2 hr at room temperature. The plates
neither the phosphotyrosine binding sites within the Syk were then blocked with heat-inactivated BSA and washed. Phosphopep-
tide FcRI ITAM (10 M), followed by the soluble His-tagged integrinSH2 domains nor phosphorylation of tyrosines in the 3
cytoplasmic-domain model protein (2.5 M), were added. After a 1 hrtail is required for Syk interaction with, or activation [5]
incubation, bound integrin cytoplasmic-domain model proteins were de-by, 3 integrins. Thus, integrins and immune receptors tected with anti-His antibodies and secondary HRP-conjugated antibodies.
have evolved distinct mechanisms for recruiting Syk to
transmembrane receptor complexes. Syk is recruited to Phosphorylation and coprecipitation
clustered integrins by its direct interaction with integrin Adhesion-dependent phosphorylation assays were carried out as per-
formed previously [5]. For coprecipitation, cells (CHO cells or platelets)cytoplasmic domains. Src kinases are present in these
on BSA or fibrinogen (1 hr at 37
C) were lysed in 50 mM Tris (pH 7.4)integrin-dependent protein complexes [15] and are re-
containing 0.5% Nonidet P-40, 50 mM NaCl, and a protease inhibitorquired for maximal integrin-dependent activation of Syk cocktail (Boehringer Mannheim, Germany). After clarification at 12,000
[5]. Thus, the proximity promoted by integrin clustering rpm for 20 min, 500–750 g of lysate was incubated with primary
antibody (either polyclonal antibody 8053 for 3 integrins or polyclonalmay promote Syk transphosphorylation by one or more
antibody 0134 for Syk) overnight at 4
C. Protein A beads (25 l packed,Src family kinase [1] and lead to activation of Syk catalytic
Amersham Pharmacia Biotech ) were then added and rotated for 2 hractivity [16]. at 4
C.
Confocal microscopySyk is regulated by multiple classes of integrins (1 [17],
Lamellipodia quantification was carried out as previously described [6].
2 [18], and 3 [4]), and Syk binds to multiple classes of
integrin tails (2, 5, 7, and 1A, unpublished results) Supplementary material
in addition to 3. Furthermore, 3 tails bind the Syk For additional methodological details, see the supplementary material
available with the electronic version of this article at http://images.paralog, Zap-70, which is also subject to integrin-depen-
cellpress.com/supmat/supmatin.htm.dent regulation [19]. Thus, the direct interaction between
integrin cytoplasmic domains and either Syk or ZAP-70
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